GlassScriptPhysician profile
Bradley Harman
NPI 1467458653
$7,168.82
in general payments reported to CMS, 2019-2025
19 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,699 · 2020: $1,714 · 2021: $141 · 2022: $1,508 · 2023: $132 · 2024: $1,849 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253 · Travel and Lodging: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,252.68 |
| Travel and Lodging | $854.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $3,128.29 | 2019-2024 | |
| Arthrex, INC. | $2,659.82 | 2020-2024 | |
| Zimmer Biomet Holdings, INC. | $271.81 | 2019-2022 | |
| Stryker Corporation | $217.33 | 2019-2025 | Augment Injectable, Pangea |
| Ferring Pharmaceuticals INC. | $193.00 | 2020-2024 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $152.81 | 2022-2025 | Exparel |
| Medical Device Business Services, INC. | $127.32 | 2024 | Surgicel Nu-Knit |
| Ethicon US, LLC | $103.82 | 2023-2024 | Stratafix, Dermabond Prineo, Surgiflo Hemostatic Matrix |
| Pacira Therapeutics, INC. | $50.91 | 2019-2020 | |
| Depuy Synthes Sales INC. | $49.72 | 2019-2025 | Monovisc |
| Abbvie INC. | $48.64 | 2021-2022 | |
| Abbott Laboratories | $34.37 | 2024-2025 | Proclaim, Ionicrf |
| Smith+Nephew, INC. | $32.93 | 2019-2021 | |
| Horizon Therapeutics Plc | $29.28 | 2019 | |
| Baxter Healthcare | $21.60 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.44 | 2023 | Intellis Adaptivestim |
| Integra Lifesciences Corporation | $11.82 | 2022 | |
| Vericel Corporation | $11.24 | 2019 | |
| Heraeus Medical, LLC. | $10.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Harman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.